Skip to main content
Erschienen in: Abdominal Radiology 7/2019

30.03.2019 | Pelvis

Precision and accuracy of magnetic resonance imaging for lobar classification of benign prostatic hyperplasia

verfasst von: Neil F. Wasserman, Eric Niendorf, Benjamin Spilseth

Erschienen in: Abdominal Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To validate the application of a magnetic resonance imaging (MRI)-based lobar classification of benign prostatic hyperplasia (BPH) for use in research and clinical management.

Methods

Two radiologists with 5 and 11 years post-fellowship experience were trained in the lobar classification of BPH using an internally developed atlas of prostate anatomy with example MRI images edited by a third senior radiologist designated as the “administrator” of the study. A study population of 140 patients referred to a tertiary academic medical center with known or suspected prostate cancer was selected by the administrator to test the interrater reliability (IRR; precision) of the classification as well as accuracy of the two readers compared to the administrator as the “gold” standard. The intrarater reliability of repeat readings of the administrator was also examined. Percentage of agreement, proportion of agreement, and Cohen’s κ were applied. This was a retrospective IRB-approved study.

Results

IRR (precision) between the two interpreting radiologists was 64% agreement, corresponding to unweighted κ of 0.52. Composite proportion of agreement across all BPH types (categories) for interpreting radiologists was 0.67. Observer accuracy was 62% agreement, unweighted κ 0.49, for observer 1 and 67%, unweighted κ 0.58, for observer 2. Intrarater reliability for the administrator was 87% agreement, unweighted κ 0.81 with composite proportion of agreement across all categories of 0.87.

Conclusions

MRI lobar classification of BPH is a reproducible and reliable tool for research and clinical applications.
Literatur
1.
Zurück zum Zitat Maserejian N.N., Chen S., Chiu G.R., et al: Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology (2013); 82:560–564CrossRefPubMed Maserejian N.N., Chen S., Chiu G.R., et al: Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology (2013); 82:560–564CrossRefPubMed
2.
Zurück zum Zitat Saigal C, Joyce G, Geschwind S, et al. (2004) Methods. In Litwin MS, Saigal CS (eds): Urologic diseases in America. Washington, DC: US Government Publishing Office. pp 283–316 Saigal C, Joyce G, Geschwind S, et al. (2004) Methods. In Litwin MS, Saigal CS (eds): Urologic diseases in America. Washington, DC: US Government Publishing Office. pp 283–316
3.
Zurück zum Zitat Taub DA, Wei JT (2006) The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep 7:272–281CrossRefPubMed Taub DA, Wei JT (2006) The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep 7:272–281CrossRefPubMed
4.
Zurück zum Zitat Vuichoud C, Loughlin KR. (2015) Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 22(Suppl 1):1–6PubMed Vuichoud C, Loughlin KR. (2015) Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 22(Suppl 1):1–6PubMed
5.
Zurück zum Zitat Barry MJ, Beckley S, Boyle P, et al. Importance of understanding the epidemiology and natural history of BPH. In: Cockett ATK, Aso Y, Chatelain C, et al (eds) (1991) Proceedings of the International consultation on benign prostatic hyperplasia (BPH). Paris: Scientific Communications International Ltd.; p. 37 Barry MJ, Beckley S, Boyle P, et al. Importance of understanding the epidemiology and natural history of BPH. In: Cockett ATK, Aso Y, Chatelain C, et al (eds) (1991) Proceedings of the International consultation on benign prostatic hyperplasia (BPH). Paris: Scientific Communications International Ltd.; p. 37
7.
Zurück zum Zitat Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padles RJ (1996) The efficiency of terazosin, finasteride or both in benign prostatic hyperplasia. N Engl J Med 335: 533–9.CrossRefPubMed Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padles RJ (1996) The efficiency of terazosin, finasteride or both in benign prostatic hyperplasia. N Engl J Med 335: 533–9.CrossRefPubMed
8.
Zurück zum Zitat Randall A (1931). Surgical pathology of prostatic obstructions. Baltimore (MD): Williams and Wilkins Randall A (1931). Surgical pathology of prostatic obstructions. Baltimore (MD): Williams and Wilkins
9.
Zurück zum Zitat Wasserman NF (2006) Benign prostatic hyperplasia: a review and ultrasound classification. Radiol Clin N Am 44:689–710ßCrossRefPubMed Wasserman NF (2006) Benign prostatic hyperplasia: a review and ultrasound classification. Radiol Clin N Am 44:689–710ßCrossRefPubMed
10.
Zurück zum Zitat Wasserman NF, Spilseth B, Golzerian J, Metzger BJ (2015) Use of MRI for lobar classification of benign prostatic hyperplasia: potential phenotypic biomarkers for research on treatment. AJR 205:564–571CrossRefPubMed Wasserman NF, Spilseth B, Golzerian J, Metzger BJ (2015) Use of MRI for lobar classification of benign prostatic hyperplasia: potential phenotypic biomarkers for research on treatment. AJR 205:564–571CrossRefPubMed
11.
Zurück zum Zitat Golzarian J, Antunes AA, Bilhim T, Carnevale FC, Konety B, McVary KT, Parsons JK, Pisco JM, Siegel DN, Spies J, Wasserman N, Gowda N, Ahrar K (2014) Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel. Journal of Vascular and Interventional Radiology. 25(5):665–74 [Consensus Development Conference] Golzarian J, Antunes AA, Bilhim T, Carnevale FC, Konety B, McVary KT, Parsons JK, Pisco JM, Siegel DN, Spies J, Wasserman N, Gowda N, Ahrar K (2014) Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel. Journal of Vascular and Interventional Radiology. 25(5):665–74 [Consensus Development Conference]
12.
Zurück zum Zitat Guneyli S, Ward E, Peng Y, Nehal Yousuf A, Trilisky I, Westin C, Antic T, Oto A (2017) MRI evaluation of benign prostatic hyperplasia: correlation with international prostate symptom score. J Magnetic Resonance Imaging 45:917–925CrossRef Guneyli S, Ward E, Peng Y, Nehal Yousuf A, Trilisky I, Westin C, Antic T, Oto A (2017) MRI evaluation of benign prostatic hyperplasia: correlation with international prostate symptom score. J Magnetic Resonance Imaging 45:917–925CrossRef
13.
Zurück zum Zitat Grivas N, van der Roest R, Tillier C, Schouten D, van Muilekrom E, Schoots IHeijmink S (2017) Patterns of benign prostate hyperplasia based on magnetic resonance imaging are correlated with lower urinary tract symptoms and continence in men undergoing robot-assisted radical prostatectomy for prostate cancer. Urology Grivas N, van der Roest R, Tillier C, Schouten D, van Muilekrom E, Schoots IHeijmink S (2017) Patterns of benign prostate hyperplasia based on magnetic resonance imaging are correlated with lower urinary tract symptoms and continence in men undergoing robot-assisted radical prostatectomy for prostate cancer. Urology
14.
Zurück zum Zitat Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the κ statistic. Fam Med. 37:360–363PubMed Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the κ statistic. Fam Med. 37:360–363PubMed
15.
Zurück zum Zitat Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas. 20:37–46.CrossRef Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas. 20:37–46.CrossRef
16.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
17.
Zurück zum Zitat de la Talle A, Viellefond A, Berger N, Boucher N, De Fromont M, Fondimare A, Moliné V, Piron D, Sibony M, Staroz D, Triller M, Peltier E, Thiounn N, Rubin MA (2003) Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays. Human Pathol 34:444–449CrossRef de la Talle A, Viellefond A, Berger N, Boucher N, De Fromont M, Fondimare A, Moliné V, Piron D, Sibony M, Staroz D, Triller M, Peltier E, Thiounn N, Rubin MA (2003) Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays. Human Pathol 34:444–449CrossRef
18.
Zurück zum Zitat Allsbrook WC, Jr, Mangold KA, Johnson MH, et al (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists. Hum Pathol 32:74–80CrossRef Allsbrook WC, Jr, Mangold KA, Johnson MH, et al (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists. Hum Pathol 32:74–80CrossRef
19.
Zurück zum Zitat Allsbrook WC Jr, Mangold KA, Johnson MH, et al (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologist. Human Pathol 32:81–88CrossRef Allsbrook WC Jr, Mangold KA, Johnson MH, et al (2001) Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologist. Human Pathol 32:81–88CrossRef
20.
Zurück zum Zitat Melia J, Moseley R, Ball RY, Griffiths DFR, Grigor K, Harnden P, Jarmulowicz M, McWilliam LJ, Montironi R, Waller M, Moss S, Parkinson MC (2006) A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology 48:644–654CrossRefPubMed Melia J, Moseley R, Ball RY, Griffiths DFR, Grigor K, Harnden P, Jarmulowicz M, McWilliam LJ, Montironi R, Waller M, Moss S, Parkinson MC (2006) A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology 48:644–654CrossRefPubMed
21.
Zurück zum Zitat Kronz JD, Silberman MA, Allsbrook WC Jr, et al (2000) Pathology residents’ use of a web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies. Hum Pathol 31:1044–1150CrossRefPubMed Kronz JD, Silberman MA, Allsbrook WC Jr, et al (2000) Pathology residents’ use of a web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies. Hum Pathol 31:1044–1150CrossRefPubMed
22.
Zurück zum Zitat Egevad L (2001) Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images. Urology 57:291–295CrossRefPubMed Egevad L (2001) Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images. Urology 57:291–295CrossRefPubMed
23.
Zurück zum Zitat Bain GO, Koch M, Hanson J (1982) Feasibility of grading carcinomas. Arch Pathol Lab Med 106:265–267 Bain GO, Koch M, Hanson J (1982) Feasibility of grading carcinomas. Arch Pathol Lab Med 106:265–267
24.
Zurück zum Zitat Gleason DF (1992) Histologic grading of prostate cancer: A perspective. Hum Pathol 23:273–279CrossRefPubMed Gleason DF (1992) Histologic grading of prostate cancer: A perspective. Hum Pathol 23:273–279CrossRefPubMed
25.
Zurück zum Zitat Cintra ML, Billis A (1991) Histologic grading of prostatic adenocarcinoma: Intraobserver reproducibility of the Mostofi, Gleason and Bocking Systems. Int Urol Nephrol 23:449–454CrossRefPubMed Cintra ML, Billis A (1991) Histologic grading of prostatic adenocarcinoma: Intraobserver reproducibility of the Mostofi, Gleason and Bocking Systems. Int Urol Nephrol 23:449–454CrossRefPubMed
26.
Zurück zum Zitat Rousselet MC, Saint-Andre JP, Six P, et al (1986) Reproductibilite et valeur pronostique des grades histologiques de Gleason et de Gaeta dans les carcinomes de la prostate. Ann Urol 20:317–322 Rousselet MC, Saint-Andre JP, Six P, et al (1986) Reproductibilite et valeur pronostique des grades histologiques de Gleason et de Gaeta dans les carcinomes de la prostate. Ann Urol 20:317–322
27.
Zurück zum Zitat Harada M, Mostofi FK, Corle DK, et al (1977) Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61:223–225PubMed Harada M, Mostofi FK, Corle DK, et al (1977) Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61:223–225PubMed
28.
Zurück zum Zitat Vaché T, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Rouvière, O. (2014) Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology 272:446–455CrossRefPubMed Vaché T, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Rouvière, O. (2014) Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology 272:446–455CrossRefPubMed
29.
Zurück zum Zitat Muller, B. G., Shih, J. H., Sankineni, S. et al. (2015) Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology, 277: 741CrossRefPubMed Muller, B. G., Shih, J. H., Sankineni, S. et al. (2015) Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology, 277: 741CrossRefPubMed
30.
Zurück zum Zitat Renard-Penna R, Mozer P, Cornud F, Barry-Delongchamp N, Bruguière E, Portalez D, Malavaud B (2015) Prostate imaging reporting and data system and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy. Radiology 275:458–468CrossRefPubMed Renard-Penna R, Mozer P, Cornud F, Barry-Delongchamp N, Bruguière E, Portalez D, Malavaud B (2015) Prostate imaging reporting and data system and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy. Radiology 275:458–468CrossRefPubMed
31.
Zurück zum Zitat Schimmöller L, Quentin M, Arsov C, et al (2013) Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 23(11):3185–3190CrossRefPubMed Schimmöller L, Quentin M, Arsov C, et al (2013) Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 23(11):3185–3190CrossRefPubMed
32.
Zurück zum Zitat McHugh ML. Interrater reliability: the κ statistic. (2012) Biochem Med (Zagreb); 22(3):276–282.CrossRef McHugh ML. Interrater reliability: the κ statistic. (2012) Biochem Med (Zagreb); 22(3):276–282.CrossRef
33.
Zurück zum Zitat Meikle AW, Stephenson RA, Lewis CM, Middleton RG (1997) Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinology and Metabolism. 82:571–575 Meikle AW, Stephenson RA, Lewis CM, Middleton RG (1997) Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinology and Metabolism. 82:571–575
34.
Zurück zum Zitat Tan YH, Foo KT (2003) Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J Urol. 170:2339–2341CrossRefPubMed Tan YH, Foo KT (2003) Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J Urol. 170:2339–2341CrossRefPubMed
35.
Zurück zum Zitat Shin SH, Kim JW, Kim JW, Oh MM, Moon DG (2013) Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction. Korean J Urol 54:369–372CrossRefPubMedPubMedCentral Shin SH, Kim JW, Kim JW, Oh MM, Moon DG (2013) Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction. Korean J Urol 54:369–372CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Lee SW, Cho JM, Kang JY, Yoo TK. (2010) Clinical and urodynamic significance of morphological differences in intravesical prostatic protrusion. Korean J Urol 51:694–699CrossRefPubMedPubMedCentral Lee SW, Cho JM, Kang JY, Yoo TK. (2010) Clinical and urodynamic significance of morphological differences in intravesical prostatic protrusion. Korean J Urol 51:694–699CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Cumpanas A, Botoca M, Minciu R, Bucuras V (2013) Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin. Urology 81:859–863CrossRefPubMed Cumpanas A, Botoca M, Minciu R, Bucuras V (2013) Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin. Urology 81:859–863CrossRefPubMed
Metadaten
Titel
Precision and accuracy of magnetic resonance imaging for lobar classification of benign prostatic hyperplasia
verfasst von
Neil F. Wasserman
Eric Niendorf
Benjamin Spilseth
Publikationsdatum
30.03.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01970-z

Weitere Artikel der Ausgabe 7/2019

Abdominal Radiology 7/2019 Zur Ausgabe

Classics in Abdominal Radiology

Fadeout sign of liver

Classics in Abdominal Radiology

Thimble bladder

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.